The First Clinical College of Zhejiang Chinese Medical University, 548 Binwen, Hangzhou, Zhejiang, 310053, China.
The Second Clinical College of Zhejiang, Chinese Medical University, 548 Binwen, Hangzhou, Zhejiang, 310053, China.
Sci Rep. 2024 Oct 26;14(1):25550. doi: 10.1038/s41598-024-77273-1.
Observational studies and clinical trials have suggested the relationship between the gut microbiome and respiratory diseases, but the causality between them remains unclear. Firstly, we selected eight respiratory diseases Genome-wide association study (GWAS) datasets mainly from the FinnGen collaboration as outcomes. The exposure was based on GWAS statistics about the gut microbiome, sourced from the MiBioGen consortium, including gut microbial taxa. The causal link between the gut microbiome and respiratory illnesses was then estimated using a Two-sample Mendelian randomization (MR) analysis, including the inverse-variance weighted (IVW), weighted median, MR-Egger, simple mode, and weighted mode. To ensure reliability, F-statistics and sensitivity tests were conducted. Furthermore, we performed a reverse MR analysis of the pre-Mendelian positive findings to possible reverse causality. For the 196 gut microbe taxa, the IVW analysis suggested 88 potential associations with eight clinically prevalent respiratory diseases. Among them, 30 causal associations were found in more than one MR method. Multiple statistical corrections have confirmed three causal associations: genus Holdemanella was a risk factor for chronic obstructive pulmonary disease (COPD) (P = 1.3 × 10, OR = 1.18), family FamilyXIII was a protective factor for COPD (P = 1.3 × 10, OR = 0.75), and genus Oxalobacter was a risk factor for asthma (P = 2.1 × 10, OR = 1.09). Our MR analysis results indicate that there would be a causal relationship between the gut microbiome and respiratory diseases, contributing to the gut-lung axis. This finding offers new insights into the gut microbiome's roles in respiratory diseases' clinical prevention, pathogenesis, and improvement of clinical symptoms. Further randomized controlled trials are necessary to clarify the protective effect of probiotics and fecal microbial transplantation on respiratory health.
观察性研究和临床试验表明肠道微生物组与呼吸道疾病之间存在关联,但它们之间的因果关系尚不清楚。首先,我们选择了八项主要来自 FinnGen 合作的呼吸道疾病全基因组关联研究 (GWAS) 数据集作为结局。暴露基于来自 MiBioGen 联盟的肠道微生物组的 GWAS 统计数据,包括肠道微生物类群。然后使用两样本孟德尔随机化 (MR) 分析估计肠道微生物组与呼吸道疾病之间的因果关系,包括逆方差加权 (IVW)、加权中位数、MR-Egger、简单模式和加权模式。为了确保可靠性,进行了 F 统计量和敏感性测试。此外,我们对可能存在反向因果关系的前孟德尔阳性发现进行了反向 MR 分析。对于 196 种肠道微生物,IVW 分析表明 88 种潜在的关联与八种临床常见的呼吸道疾病有关。其中,30 种因果关联在多种 MR 方法中得到了验证。多种统计校正证实了三种因果关联:属 Holdemanella 是慢性阻塞性肺疾病 (COPD) 的危险因素 (P = 1.3×10, OR = 1.18),科 FamilyXIII 是 COPD 的保护因素 (P = 1.3×10, OR = 0.75),属 Oxalobacter 是哮喘的危险因素 (P = 2.1×10, OR = 1.09)。我们的 MR 分析结果表明,肠道微生物组与呼吸道疾病之间存在因果关系,这有助于阐明肠道-肺部轴。这一发现为肠道微生物组在呼吸道疾病的临床预防、发病机制和改善临床症状方面的作用提供了新的见解。需要进一步的随机对照试验来阐明益生菌和粪便微生物移植对呼吸道健康的保护作用。